| Yasser Salem, MD | |
|
4301 W Markham St # 783, Little Rock, AR 72205-7101 | |
| (501) 686-8000 | |
| Not Available |
| Full Name | Yasser Salem |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 33 Years |
| Location | 4301 W Markham St # 783, Little Rock, Arkansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184714651 | NPI | - | NPPES |
| P00351548 | Other | AR | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | E-4482 (Arkansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Uams Medical Center | Little rock, AR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Arkansas | 4082528955 | 1121 |
News Archive
Galapagos NV announced today that it has started a Phase II clinical study to evaluate Nanocort's effectiveness in treating flares in multiple sclerosis (MS). Nanocort combines less frequent treatment with lower dosage and potentially more effective delivery than other MS flare treatments.
Picwell, the most advanced predictive recommendation engine for health plan selection, today announced finalized agreements to conduct studies focused on the potential impact of latest generation decision support systems on consumer health plan selection.
Thermo Fisher Scientific Inc., the world leader in serving science, today introduced the Thermo Scientific HyPerforma Single-Use Bioreactor TK (S.U.B. TK), an integrated system that combines the company's proven single-use bioreactor technology with a robust controller platform that enhances functionality and greatly reduces setup times before each production run.
Chagas disease is the main cause of infectious heart disease in Latin America. Researchers from the INGEBI and IBYME Institutes in Argentina explored the effect of glycan binding protein interactions between the human host and Typanosoma cruzi parasite. They found that a glycan binding protein expressed in humans modified the infection in cells of the heart muscle, showing the importance of galectins in the response to parasite infection.
One year after giving birth, women were less likely to have the most dangerous kind of obesity if they had been given probiotics from the first trimester of pregnancy, found new research that suggests manipulating the balance of bacteria in the gut may help fight obesity.
› Verified 1 days ago
| Entity Name | University Of Arkansas For Medical Sciences |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588654016 PECOS PAC ID: 4082528955 Enrollment ID: O20031219000706 |
News Archive
Galapagos NV announced today that it has started a Phase II clinical study to evaluate Nanocort's effectiveness in treating flares in multiple sclerosis (MS). Nanocort combines less frequent treatment with lower dosage and potentially more effective delivery than other MS flare treatments.
Picwell, the most advanced predictive recommendation engine for health plan selection, today announced finalized agreements to conduct studies focused on the potential impact of latest generation decision support systems on consumer health plan selection.
Thermo Fisher Scientific Inc., the world leader in serving science, today introduced the Thermo Scientific HyPerforma Single-Use Bioreactor TK (S.U.B. TK), an integrated system that combines the company's proven single-use bioreactor technology with a robust controller platform that enhances functionality and greatly reduces setup times before each production run.
Chagas disease is the main cause of infectious heart disease in Latin America. Researchers from the INGEBI and IBYME Institutes in Argentina explored the effect of glycan binding protein interactions between the human host and Typanosoma cruzi parasite. They found that a glycan binding protein expressed in humans modified the infection in cells of the heart muscle, showing the importance of galectins in the response to parasite infection.
One year after giving birth, women were less likely to have the most dangerous kind of obesity if they had been given probiotics from the first trimester of pregnancy, found new research that suggests manipulating the balance of bacteria in the gut may help fight obesity.
› Verified 1 days ago
| Entity Name | University Of Arkansas For Medical Sciences |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346230968 PECOS PAC ID: 4082528955 Enrollment ID: O20040115000431 |
News Archive
Galapagos NV announced today that it has started a Phase II clinical study to evaluate Nanocort's effectiveness in treating flares in multiple sclerosis (MS). Nanocort combines less frequent treatment with lower dosage and potentially more effective delivery than other MS flare treatments.
Picwell, the most advanced predictive recommendation engine for health plan selection, today announced finalized agreements to conduct studies focused on the potential impact of latest generation decision support systems on consumer health plan selection.
Thermo Fisher Scientific Inc., the world leader in serving science, today introduced the Thermo Scientific HyPerforma Single-Use Bioreactor TK (S.U.B. TK), an integrated system that combines the company's proven single-use bioreactor technology with a robust controller platform that enhances functionality and greatly reduces setup times before each production run.
Chagas disease is the main cause of infectious heart disease in Latin America. Researchers from the INGEBI and IBYME Institutes in Argentina explored the effect of glycan binding protein interactions between the human host and Typanosoma cruzi parasite. They found that a glycan binding protein expressed in humans modified the infection in cells of the heart muscle, showing the importance of galectins in the response to parasite infection.
One year after giving birth, women were less likely to have the most dangerous kind of obesity if they had been given probiotics from the first trimester of pregnancy, found new research that suggests manipulating the balance of bacteria in the gut may help fight obesity.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Yasser Salem, MD 4301 W Markham St # 783, Little Rock, AR 72205-7101 Ph: (501) 686-8000 | Yasser Salem, MD 4301 W Markham St # 783, Little Rock, AR 72205-7101 Ph: (501) 686-8000 |
News Archive
Galapagos NV announced today that it has started a Phase II clinical study to evaluate Nanocort's effectiveness in treating flares in multiple sclerosis (MS). Nanocort combines less frequent treatment with lower dosage and potentially more effective delivery than other MS flare treatments.
Picwell, the most advanced predictive recommendation engine for health plan selection, today announced finalized agreements to conduct studies focused on the potential impact of latest generation decision support systems on consumer health plan selection.
Thermo Fisher Scientific Inc., the world leader in serving science, today introduced the Thermo Scientific HyPerforma Single-Use Bioreactor TK (S.U.B. TK), an integrated system that combines the company's proven single-use bioreactor technology with a robust controller platform that enhances functionality and greatly reduces setup times before each production run.
Chagas disease is the main cause of infectious heart disease in Latin America. Researchers from the INGEBI and IBYME Institutes in Argentina explored the effect of glycan binding protein interactions between the human host and Typanosoma cruzi parasite. They found that a glycan binding protein expressed in humans modified the infection in cells of the heart muscle, showing the importance of galectins in the response to parasite infection.
One year after giving birth, women were less likely to have the most dangerous kind of obesity if they had been given probiotics from the first trimester of pregnancy, found new research that suggests manipulating the balance of bacteria in the gut may help fight obesity.
› Verified 1 days ago
Faber A White, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1701 S Shackleford Rd, Little Rock, AR 72211 Phone: 501-219-7481 | |
Louis W Sessions, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 9601 Interstate 630 Exit 7, Little Rock, AR 72205 Phone: 501-202-2093 | |
David M Dean, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 9601 Interstate 630 Exit 7, Little Rock, AR 72205 Phone: 501-202-2093 | |
Ken Wade, CRNA Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 9601 Interstate 630 Exit 7, Little Rock, AR 72205 Phone: 501-202-2093 | |
Garry Jones, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 500 S University Ave, Suite 505, Little Rock, AR 72205 Phone: 501-664-4532 Fax: 501-663-4335 | |
Mrs. Tatiana Puntarelli, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 1 Childrens Way # 203, Little Rock, AR 72202 Phone: 501-364-1100 Fax: 501-364-4082 | |
Gregory Ryan Mehaffey, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 4301 W Markham St # 783, Little Rock, AR 72205 Phone: 501-686-8000 |